Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 5/2006

01-06-2006 | Case Report

Clinical Features of Polycythemia Vera and Essential Thrombocythemia in Japan: Retrospective Analysis of a Nationwide Survey by the Japanese Elderly Leukemia and Lymphoma Study Group

Authors: Kazuo Dan, Takashi Yamada, Yukihiko Kimura, Noriko Usui, Shinichirou Okamoto, Takashi Sugihara, Kazue Takai, Michihiko Masuda, Mayumi Mori, Japanese Elderly Leukemia and Lymphoma Study Group

Published in: International Journal of Hematology | Issue 5/2006

Login to get access
Metadata
Title
Clinical Features of Polycythemia Vera and Essential Thrombocythemia in Japan: Retrospective Analysis of a Nationwide Survey by the Japanese Elderly Leukemia and Lymphoma Study Group
Authors
Kazuo Dan
Takashi Yamada
Yukihiko Kimura
Noriko Usui
Shinichirou Okamoto
Takashi Sugihara
Kazue Takai
Michihiko Masuda
Mayumi Mori
Japanese Elderly Leukemia and Lymphoma Study Group
Publication date
01-06-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06009

Other articles of this Issue 5/2006

International Journal of Hematology 5/2006 Go to the issue

Letter to the Editor

Severe Hemorrhage from Gastric Vascular Ectasia Developed in a Patient with AML

Letter to the Editor

A Case of Non-Hodgkin’s Lymphoma and Invasive Thymoma Treated with R-Chop Therapy

Progress in Hematology

Molecular Pathogenesis of Hodgkin Lymphoma

Progress in Hematology

Genomic Alterations in Hodgkin’s Lymphoma

Case Report

Jaw Osteonecrosis Associated with Use of Bisphosphonates and Chemotherapy: Paradoxical Complication of Treatment of Bone Lesions in Multiple Myeloma Patients

Case Report

Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits